Champlain Investment Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87.4M Sell
731,680
-111,500
-13% -$14.6M 1.11% 33
2025
Q4
$115M Sell
843,180
-384,600
-31% -$55.3M 1.16% 31
2025
Q3
$181M Sell
1,227,780
-379,179
-24% -$52.6M 1.37% 14
2025
Q2
$208M Sell
1,606,959
-3,055
-0.2% -$370K 1.45% 9
2025
Q1
$192M Sell
1,610,014
-159,781
-9% -$19.8M 1.39% 12
2024
Q4
$205M Buy
1,769,795
+112,010
+7% +$14.2M 1.3% 22
2024
Q3
$224M Buy
1,657,785
+249,975
+18% +$33.4M 1.35% 20
2024
Q2
$191M Sell
1,407,810
-323,975
-19% -$44.1M 1.17% 31
2024
Q1
$224M Sell
1,731,785
-556,676
-24% -$67.3M 1.28% 23
2023
Q4
$262M Buy
2,288,461
+106,490
+5% +$10.6M 1.55% 12
2023
Q3
$199M Buy
2,181,971
+1,005,724
+86% +$104M 1.29% 17
2023
Q2
$132M Buy
1,176,247
+655,222
+126% +$69.3M 0.82% 50
2023
Q1
$54.6M Buy
+521,025
New +$54.4M 0.34% 101

Other funds holding XYL

Champlain Investment Partners's XYL Position: Q1 2026 in Review

Champlain Investment Partners reduced its Xylem (XYL) stake by 13% in Q1 2026, selling an estimated $14.6M and leaving 731,680 shares worth $87.4M. The position accounts for 1.11% of the portfolio, ranked #33.

Champlain Investment Partners first reported a position in XYL in Q1 2023 and has held it in 13 quarters since. The position peaked at $262M in Q4 2023. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Champlain Investment Partners held 731,680 shares of Xylem worth $87.4M as of Q1 2026.
  • Champlain Investment Partners sold 111,500 Xylem shares in Q1 2026, an estimated $14.6M.
  • Xylem made up 1.11% of Champlain Investment Partners's portfolio in Q1 2026, its #33 holding.
  • Champlain Investment Partners first reported a position in Xylem in Q1 2023 and has held it in 13 quarters since.
  • Champlain Investment Partners's Xylem position peaked at $262M in Q4 2023.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.